KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial

Clinical trial NCT05635591 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT05635591
Sponsor: Tongji Hospital
Status: ENROLLING_BY_INVITATION
Phase: Phase 1
Study type: INTERVENTIONAL

EBV-associated Haematologic Neoplasms

Start date: 2023-01-16
Primary completion: 2026-12-31
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.